Premium
PROGNOSTIC VALUE OF IMMUNOHISTOCHEMICAL MARKERS IN STAGE III/IV CLASSICAL HODGKIN LYMPHOMA TREATED FRONTLINE IN THE LYSA EORTC 20012 RANDOMIZED PROTOCOL
Author(s) -
Canioni D.,
Brice P.,
Bologna S.,
Voillat L.,
Gabarre J.,
Casasnovas O.,
Devidas A.,
Coiffier B.,
Aoudjhane A.,
Audouy B.,
Andre M.,
Fortpied C.,
Carde P.,
Mounier N.,
Briere J.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2438_18
Subject(s) - dacarbazine , vincristine , medicine , abvd , procarbazine , cd15 , immunohistochemistry , vinblastine , oncology , bleomycin , pathology , chemotherapy , cyclophosphamide , biology , cd34 , stem cell , genetics